George Church and company have cooked up a scheme for harnessing components of the bacterial "clustered interspersed short palindromic repeat" and "CRISPR-associated" system — normally used in adaptive immunity — to aid in genome engineering efforts using the budding yeast Saccharomyces cerevisiae. As they report in the online edition of Nucleic Acids Research, the researchers relied on RNA-guided endonuclease activity offered by components from the type II CRISPR-Cas system.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

This Week in Cell

This Week in Nature

This Week in Nature

This Week in Science

CRISPR Excitement

This Week in Science

In PNAS this week: transcript patterns in drug-resistant cancer cells, function of high-altitude adaption gene, and more.

Monitoring gene expression changes could help sniff out athletes using performance-enhancing drugs, New Scientist says.

The University of Southern California lodges a cross-complaint in its legal dispute with the University of California, San Diego, over a large Alzheimer's disease project.

Bioethicists weigh the idea of charging patients to take part in clinical research, coming down against the approach.